Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy

This publication has 36 references indexed in Scilit:

• Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
  Kidney International, 2003
• Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients
  Nephrology Dialysis Transplantation, 2001
• The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)
  Journal of the Renin-Angiotensin-Aldosterone System, 2000
• Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
  American Journal of Kidney Diseases, 1999
• Reversal of Anemia by Erythropoietin Therapy Retards the Progression of Chronic Renal Failure, Especially in Nondiabetic Patients
  Nephron, 1997
• Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
  Kidney International, 1995
• Effectiveness and Safety of Recombinant Human Erythropoietin in Predialysis Patients
  Nephron, 1992
• Treatment of the Anemia of Progressive Renal Failure with Recombinant Human Erythropoietin
  New England Journal of Medicine, 1989
• Treatment of the Anemia of Predialysis Patients with Recombinant Human Erythropoietin: A Randomized, Placebo-Controlled Trial
  The Lancet Healthy Longevity, 1988
• Tests for Linear Trends in Proportions and Frequencies
  Published by JSTOR ,1955